FDA Announces Class I Recall of Fisher and Paykel Healthcare Infant Nasal CPAP Prongs: AttorneyOne Monitor and Keep Consumers Informed

On May 23, the FDA announced that Fisher and Paykel Healthcare Infant Nasal CPAP Prongs are recalled because prongs may detach from nasal tubing and interrupt therapy. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Fisher and Paykel Healthcare Infant Nasal CPAP Prongs Recall

Fisher and Paykel Healthcare Infant Nasal CPAP Prongs Recall

the detached prongs may present a potential risk of choking and airway obstruction

San Diego, CA (PRWEB) May 30, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for Infant Nasal CPAP Prongs.

The FDA announced on May 23, that Fisher and Paykel Healthcare Infant Nasal CPAP Prongs are recalled because prongs may detach from nasal tubing and interrupt therapy. The Nasal CPAP Prongs are used to deliver continuous positive airway pressure which involves passing air through an infant’s nose.

FDA’s reason for the recall is that there have been 24 reports in which the affected prongs detached from the nasal tubing during use, especially when mucous or moisture are present. Interruption of therapy may occur and this may cause hypoxemia. Moreover, the detached prongs may present a potential risk of choking and airway obstruction with serious, life-threatening, adverse events.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “we are determined to keep an eye on FDA announcements concerning Infant Nasal CPAP Prongs and inform the public. For that reason", he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

As the FDA informs “Starting April 11, 2014, Fisher & Paykel Healthcare sent its customers an Urgent Medical Device Recall letter. The letter identified the product, problem, and actions to be taken, which include:

  • Identify any Affected Prongs in your inventory by checking the REF and LOT number on the packaging. For Starter Kits, only the Nasal CPAP Prongs are affected and the rest of the Starter Kit is suitable for use.
  • Destroy the Affected Prongs by cutting them in half and disposing of the products.
  • Complete Section A ‘Inspection of Stock’ on the Urgent Medical Device Recall Response Form and return it to your FPH Representative.
  • Contact your FPH Representative for replacement products.”

AttorneyOne.com has further information on Infant Nasal CPAP Prongs at the website including latest major drug and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/05/prweb11893951.htm